Letters Long acting β2 agonists in adult asthma

Authors’ reply to Hasford

BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6599 (Published 06 November 2013) Cite this as: BMJ 2013;347:f6599
  1. Graeme P Currie, consultant chest physician1,
  2. Graham Douglas, consultant physician1
  1. 1Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK
  1. Graeme.currie{at}nhs.net

We thank Hasford for his comments on our article,1 2 particularly those relating to the Salmeterol Multicenter Asthma Research Trial (SMART).3 However, the trial found that the occurrence of the primary outcome (respiratory related deaths or life threatening …

View Full Text

Sign in

Log in through your institution